Cargando…
Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: a scoping review protocol
INTRODUCTION: Tumour necrosis factor (TNF)-alpha inhibitors are commonly used to treat inflammatory bowel disease (IBD). In patients with IBD who are unresponsive to their first induction dose, the implementation of an ‘accelerated’ induction dose schedule (doses more frequent than recommended in pr...
Autores principales: | Johnston, Amy, Natarajan, Sabrina, Hayes, Meghan, MacDonald, Erika, Shorr, Risa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829849/ https://www.ncbi.nlm.nih.gov/pubmed/29382683 http://dx.doi.org/10.1136/bmjopen-2017-019909 |
Ejemplares similares
-
Comparing persistence of new biologics to conventional anti-TNF alphas in adult patients with inflammatory bowel disease: a systematic review and meta-analysis protocol
por: Yiu, Tsz Hong, et al.
Publicado: (2023) -
Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial
por: Bouhuys, Marleen, et al.
Publicado: (2021) -
Is body mass index associated with symptom severity and health-related quality of life in irritable bowel syndrome? A cross-sectional study
por: Dong, Yuanjun, et al.
Publicado: (2018) -
Safety of furazolidone-containing regimen in Helicobacter pylori infection: a systematic review and meta-analysis
por: Ji, Chao-ran, et al.
Publicado: (2020) -
Epidemiology of Helicobacter pylori in Australia: a scoping review
por: Congedi, Jillian, et al.
Publicado: (2022)